This study investigated how the psoriasis-risk SNP rs610604 within the TNFAIP3 locus mechanistically drives inflammatory signaling in keratinocytes, focusing on the role of nuclear IKKα as a chromatin-associated repressor of TNFAIP3.
Genome-wide chromatin profiling showed nuclear IKKα predominantly occupies transcriptionally inactive regions and acts as a repressor of TNFAIP3; the psoriasis-risk G allele at rs610604 showed stronger, more persistent IKKα binding versus the protective T allele, suppressing TNFAIP3 and sustaining NF-κB, MAPK, and IL-17 pro-inflammatory signaling. Nuclear IKKα was found to be reduced in psoriatic lesions.
The study is primarily mechanistic and conducted in keratinocytes, so direct clinical or therapeutic efficacy data in patients are absent. The sample size and patient cohort details are not reported in the abstract. Causal direction in human psoriatic tissue (reduced nuclear IKKα as cause vs. consequence) remains unclear.
This research is currently preclinical, but it identifies nuclear IKKα and the TNFAIP3 locus as potential therapeutic targets in psoriasis, and may help explain why carriers of the rs610604 G allele have increased disease susceptibility and differential responses to TNF-targeted therapies.
Explore related topics
